OmniStar Financial Group’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-9,371
Closed -$472K 118
2022
Q2
$472K Buy
9,371
+4
+0% +$218 0.52% 71
2022
Q1
$571K Sell
9,367
-20,300
-68% -$1.21M 0.57% 70
2021
Q4
$1.95M Buy
29,667
+38
+0.1% +$2.43K 2% 6
2021
Q3
$1.86M Sell
29,629
-1,097
-4% -$70K 2.2% 6
2021
Q2
$1.85M Sell
30,726
-3,366
-10% -$195K 2.29% 6
2021
Q1
$1.88M Sell
34,092
-54,330
-61% -$3.01M 2.39% 5
2020
Q4
$4.82M Buy
88,422
+5,208
+6% +$272K 3.38% 3
2020
Q3
$4.16M Buy
83,214
+7,542
+10% +$365K 3.13% 4
2020
Q2
$3.34M Buy
+75,672
New +$3.23M 2.76% 6

Other funds holding IHI

OmniStar Financial Group's IHI Position: Q3 2022 in Review

OmniStar Financial Group sold out of iShares US Medical Devices ETF (IHI) in Q3 2022, closing a stake of 9,371 shares — an estimated $472K sold.

OmniStar Financial Group first reported a position in IHI in Q2 2020 and held it in 9 quarters. The position peaked at $4.82M in Q4 2020. 556 funds tracked by Wall St. Rank hold IHI as of Q3 2022.

  • OmniStar Financial Group reported no remaining iShares US Medical Devices ETF position as of Q3 2022 after selling out during the quarter.
  • OmniStar Financial Group sold 9,371 iShares US Medical Devices ETF shares in Q3 2022, an estimated $472K.
  • OmniStar Financial Group first reported a position in iShares US Medical Devices ETF in Q2 2020 and held it in 9 quarters.
  • OmniStar Financial Group's iShares US Medical Devices ETF position peaked at $4.82M in Q4 2020.
  • 556 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q3 2022.

Based on OmniStar Financial Group's 13F filing for Q3 2022, filed 14 Nov 2022.